Evidence map›Paper›PMID 36894531›Full record

ArticleCell death discovery2023

Transglutaminase 2 and Ferroptosis: a new liaison?

Mara Gagliardi, Valentina Saverio, Federica Rossin, Manuela D'Eletto, Marco Corazzari

Abstract readLetter
In one paragraph

Article in Cell death discovery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Role of Transglutaminase 2 in Cancer: An Update.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Ferroptosis inhibitors: past, present and future.Frontiers in pharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mara GagliardiDepartment of Health Sciences and Center for Translational Research on Autoimmune and Allergic Disease (CAAD), University of Piemonte Orientale, Novara, IT, Italy.
Valentina SaverioDepartment of Health Sciences and Center for Translational Research on Autoimmune and Allergic Disease (CAAD), University of Piemonte Orientale, Novara, IT, Italy.
Federica RossinDepartment of Biology, University of Rome Tor Vergata, Rome, IT, Italy.
Manuela D'ElettoDepartment of Biology, University of Rome Tor Vergata, Rome, IT, Italy.
Marco CorazzariDepartment of Health Sciences and Center for Translational Research on Autoimmune and Allergic Disease (CAAD), University of Piemonte Orientale, Novara, IT, Italy. marco.corazzari@uniupo.it.ORCID http://orcid.org/0000-0002-6246-5968

Funding

EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) ID#860462EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) ID #952033
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36894531
PMCPMC9998634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.